GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,689,342 | -30.0% | 34,025 | -16.1% | 0.29% | -52.7% |
| Q2 2023 | $2,414,645 | +5.1% | 40,555 | 0.0% | 0.61% | +5.7% |
| Q1 2023 | $2,297,035 | -23.5% | 40,555 | +0.2% | 0.58% | -24.9% |
| Q4 2022 | $3,004,593 | +26.7% | 40,455 | +1.7% | 0.77% | +17.5% |
| Q3 2022 | $2,371,000 | -4.5% | 39,794 | -10.0% | 0.66% | -8.6% |
| Q2 2022 | $2,483,000 | -29.9% | 44,227 | -7.8% | 0.72% | -34.4% |
| Q1 2022 | $3,540,000 | -1.4% | 47,983 | -3.5% | 1.10% | -5.1% |
| Q4 2021 | $3,591,000 | +502.5% | 49,734 | +539.3% | 1.16% | +439.7% |
| Q3 2021 | $596,000 | -0.3% | 7,779 | -35.6% | 0.21% | -43.7% |
| Q3 2020 | $598,000 | +53.7% | 12,083 | +48.0% | 0.38% | +9.5% |
| Q2 2020 | $389,000 | +8.7% | 8,163 | -3.2% | 0.35% | +7.4% |
| Q1 2020 | $358,000 | -44.8% | 8,429 | -23.4% | 0.32% | -3.3% |
| Q4 2019 | $648,000 | – | 10,999 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |